Investigation of inclusion complex of HP-γ-cyclodextrin with ceftazidime

Journal of Molecular Liquids

Volumn 224, Issue , 2016, Pages 387-392

  Misiuk, Wieslawa ^a  

^a UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ceftazidime; FT IR; Hydroxypropyl cyclodextrin; Inclusion complex; Molecular docking; NMR; UV vis

Indexed keywords

BIOCHEMISTRY; MOLECULAR MODELING; NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPIC ANALYSIS;

CEFTAZIDIME; GAMMA-CYCLODEXTRIN; INCLUSION BEHAVIOR; INCLUSION COMPLEX; MOLECULAR DOCKING; SPECTROSCOPIC FEATURES; SPECTROSCOPIC METHOD; UV/VIS;

CYCLODEXTRINS;

EID: 84991316041     PISSN: 01677322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molliq.2016.10.009     Document Type: Article

References (27)

1. [1] The Merck Index. 10th ed., 1983, Merck, Rahway, N.Y., 1913.
2. [2] Florey, K., Ceftazidime. Analytical Profiles of Drug Substances, vol. 19, 1990, Academic Press, San Diego, Ca, 95.
3. [3] Drug Information 89 Analytical Profiles of Drug Substances, vol. 19, 1990, American Society of Hospital in Pharmacists, Inc., 4630 Montgomery Avenue-Bethesda MD 201814, 111.
4. [4] Murtaza, G., Acta Pol. Pharm. 69 (2012), 581–590.
5. [5] Kawabata, Y., Wada, K., Nakatani, M., Yamada, Y., Onoue, S., Int. J. Pharm. 420 (2011), 1–10.
6. [6] Liu, M., Cen, A., Wang, Y., Wang, C., Wang, B., Sun, D., Food Chem. 168 (2015), 27–275.
7. [7] Liu, C., Zhang, W., Yang, H., Sun, W., Gong, X., Zhao, J., Sun, Y., Diao, G., PLoS One, 9, 2014, e101761.
8. [8] Jung, M., Mennini, N., Kover, K.E., Mura, P., J. Pharm. Biomed. Anal. 91 (2014), 81–91.
9. [9] Bushman, H.J., Schollmeyer, E.J., J. Cosmet. Sci. 53 (2002), 185–191.
10. [10] Astray, G., Gonzalez-Barreiro, C., Mejuto, J.C., Rial-Otero, R., Simal-Gandara, J.A., Food Hydrocoll. 23 (2009), 1631–1640.
11. [11] Loftsson, T., Brewster, M.E., Adv. Drug Deliv. Rev. 59 (2007), 645–666.
12. [12] Misiuk, W., Zalewska, M., Carbohydr. Polym. 77 (2009), 482–488.
13. [13] Misiuk, W., Jasiuk, E., J. Mol. Struct. 1060 (2014), 272–279.
14. [14] Misiuk, W., Jozefowicz, M., J. Mol. Liq. 202 (2015), 101–106.
15. [15] Misiuk, W., Zalewska, M., Anal. Lett. 41 (2008), 543–560.
16. [16] Desai, C., Prabhakar, B., J. Incl. Phenom. Macrocycl. Chem. 81 (2014), 175–191.
17. [17] Ol'khovich, M.V., Sharapova, A.V., Lavrenov, S.N., Blokhina, S.V., Perlovich, G.L., Fluid Phase Equilib. 384 (2014), 68–72.
18. [18] Omari, M.M., Badwan, A.A., Zughul, M.B., Davies, J.E.D., Drug Dev. Ind. Pharm. 33 (2007), 1205–1215.
19. [19] Job, P., Ann. Chim. 9 (1928), 113–203.
20. [20] Chakraborty, S., Basu, S., Lahiri, A., Basak, S., J. Mol. Struct. 977 (2010), 180–188.
21. [21] Jullian, C., Miranda, S., Zapata-Torres, G., Mendizabal, F., Olea-Azar, C., Bioorg. Med. Chem. 15 (2007), 3217–3224.
22. [22] Jullian, C., Morales-Montecinos, J., Zapata-Torres, G., Aguilera, B., Rodriguez, J., Aran, V., et al. Bioorg. Med. Chem. 16 (2008), 5078–5084.
23. [23] Zhang, J.Q., Jiang, K.M., Xie, X.G., Jin, Y., Lin, J., J. Mol. Liq. 219 (2016), 592–598.
24. [24] Liao, Y., Zhang, X., Li, C., Huang, Y., Lei, M., Yan, M., Zhou, Y., Zhao, C., Carbohydr. Polym. 147 (2016), 415–425.
25. [25] Srinivasan, K., Stalin, T., Sivakumar, K., Spectrochim. Acta A 94 (2012), 89–100.
26. [26] Seridi, L., Boufelfel, A., J. Mol. Liq. 158 (2011), 151–158.
27. [27] European Pharmacopoeia. 7th ed., 2011, Council of Europe, Strasbourg.